Genscript Biotech Corporation (FRA:G51)

Genscript Biotech Revenue

Genscript Biotech had revenue of $518.77M USD in the half year ending June 30, 2025, with 32.57% growth. This brings the company's revenue in the last twelve months to $828.10M, up 63.20% year-over-year. In the year 2024, Genscript Biotech had annual revenue of $594.49M with 6.07% growth.

• Revenue (ttm): $828.10M
• Revenue Growth: +63.20%
• P/S Ratio: 5.21
• Revenue / Employee: $148.72K
• Employees: 5,568
• Market Cap: 3.67B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	594.49M	34.01M	6.07%
Dec 31, 2023	560.48M	-65.22M	-10.42%
Dec 31, 2022	625.70M	135.60M	27.67%
Dec 31, 2021	490.10M	99.25M	25.39%
Dec 31, 2020	390.85M	117.49M	42.98%